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sequelae) are added using the differences between survivor curves
of Hepatitis B infected persons and population survivor curves.
RESULTS: Without the inclusion of future unrelated medical
costs, Hepatitis B vaccination costs €900 per life year gained.
Adjusting the ICER for these costs results in an increase to
approximately €5.700 per life year gained. CONCLUSIONS: We
conclude that the adjusted ICER provides more evidence-based
and transparant information about the real cost-effectiveness of
an intervention.
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UTILITIES SHOULD NOT BE MULTIPLIED: EVIDENCE FROM
THE PREFERENCE-BASED SCORES INTHE UNITED STATES
Fu AZ, Kattan MW
Cleveland Clinic, Cleveland, OH, USA
OBJECTIVES: Several estimators exist when average utility
scores are not available for patient populations with multiple
disease conditions. The multiplicative estimator is a widespread
choice among them. Our study is to empirically test the accuracy
of the multiplicative estimator and compare it with other estima-
tors. METHODS: The Medical Expenditure Panel Survey
(MEPS) has a nationally representative sample of the US civilian
non-institutionalized population. Using the pooled 2001 and
2003 data, a sample of 40,846 individuals with EQ-5D index
scores were categorized into 238 disease condition categories.
The study focus was the difference between the estimated and the
observed mean scores for each comorbid pair, with the observed
one presumed to be the true value. RESULTS: The scores esti-
mated by multiplying the two mean scores of the corresponding
disease conditions on average had a statistically signiﬁcantly
larger difference (p < 0.0001) from the observed ones (-0.094)
than simply picking the smaller mean of the two paired condi-
tions (difference = 0.025), the larger mean of the two (differ-
ence = 0.071), the average of the two means (difference = 0.048),
or the mean of the condition with smaller sample size of the pair
(difference = 0.049). However, the multiplicative estimator per-
formed better than the additive estimator (sum of the means
minus 1, difference = 0.123). CONCLUSIONS: Multiplication is
not a good estimate when the average utility score for patients
with two disease conditions is not readily available. The lower of
the two utility scores had the least error among those estimators
that we compared. Further research with an experimental
design is warranted before a speciﬁc alternative can be ﬁrmly
recommended.
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PATIENTS’ PREFERENCES FOR AND PRICE ELASTICITY OF
GENERIC AND BRANDED OVER-THE-COUNTER
MEDICINES—AN ADAPTIVE CONJOINT ANALYSIS
(ACA) APPROACH
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1Helsinki School of Economics, Helsinki, Finland, 2Pﬁzer Oy, Helsinki,
Finland
OBJECTIVES: Despite the increased use of generic medicines,
little is known about patients’ attitudes towards them and
patients’ decision-making process of the medicine purchased.
The aim of the study is to assess the patients’ preference struc-
ture for generic and branded over-the-counter (OTC) pain medi-
cines and their price elasticity. METHODS: Finnish university
students (n = 209) responded to an adaptive conjoint analysis
(ACA) interview. Product attributes of price, brand, onset time
of effect, place of purchase and source of information were
included on the basis of the literature, a focus group and a pilot
study. The descriptors of the respondents included socioeco-
nomic background, involvement with the purchase process, and
health behavior. Individual-level utility functions were esti-
mated, preference clusters identiﬁed, and price elasticity of the
generic medicine estimated. RESULTS: Brand and price were
the most important attributes. Even in the homogenous target
group, ﬁve clusters with characteristic preferences, price elastic-
ity and socioeconomics background were detected. Approxi-
mately half of the respondents were strongly price sensitive.
Among all the respondents, the price elasticity of a generic OTC
medicine was from -1.34 to -0.69 at the discount range of
20–60%. Even positive price elasticity was detected. In the clus-
ters with negative price elasticity, discount of 4–42% were
required to make the generic medicine equally preferred with
the branded one. In comparison with the results of our corre-
sponding study conducted before the launch of generic substi-
tution leading to common interest in generic medicines and
medicine costs in Finland, patients’ awareness of generic medi-
cines had increased, attitudes towards them were more favor-
able, and they seemed to purchase OTC medicines more
independently. CONCLUSIONS: The study provided novel
information on the concomitant effects of brand, price and
other essential product attributes on the patients’ choice of an
OTC medicine. ACA proved to be a useful tool in the research
of patients’ and patient groups’ preferences.
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OBJECTIVES: Investigate Greek adults’ perceptions of drug
effectiveness and prices. METHODS: A structured questionnaire
was used in a telephone survey in order to derive data from a
national random sample of 1000 adults, stratiﬁed by age, gender
and geographic region. Physicians and pharmacists were
excluded from the sample. The study was conducted in June
2007. The response rate was 93.0%. RESULTS: Drugs were
considered by the majority of respondents (75.7%) as safe and
effective as well as very important for medical practice (65.2%).
Respondents believed that new drugs are of a higher price
(67.8%), however these were perceived as more effective than
older ones (79.4%) Regarding the prices of drugs in Greece, one
out of two respondents believed that the prices are extremely
high. Women as opposed to men expressed the less positive
opinion on the implemented pricing policy. The majority of
respondents (81.4%) recognized that the cost of R&D should be
included into the price of the drugs, but they think that the
pricing regulation of drugs is in favor of pharmaceutical indus-
tries (90.1%). Furthermore, they expressed the opinion that
prices should be as low as possible regardless of the effectiveness.
On the other hand, they claimed that physicians should always
prescribe the most effective drug regardless of its price. The
majority of respondents (89.4%) reported that polypharmacy
and irrational prescribing are major problems in Greece and
considered doctors to be primarily responsible, followed by the
absence of audit in the health system. CONCLUSIONS: Despite
the fact that drugs prices are considered high, Greek adults have
a strong positive view regarding their safety and effectiveness.
Knowledge on both the public’s perception regarding drugs and
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the drivers of drug consumption would be beneﬁcial in ﬁnding




“ANTI-AGING-MEDICINE” FIELD: RESULTS FROM A
SYSTEMATIC HORIZON SCANNING
Storz P, Gothe H, Daroszewska A, Häussler B
IGES Institut GmbH, Berlin, Germany
OBJECTIVES: “Anti-Aging”, as an example of “preference ori-
ented medicine”, is a currently much debated ﬁeld. While it is
sometimes perceived as beneﬁcial in averting unwanted effects of
aging, improving quality of life and well-being, there is also
substantial criticism. The current investigation aims at providing
an overview on new health technologies of potential importance
for future “anti-aging” interventions. METHODS: The analysis
is based on the ZIM innovation database, which comprehen-
sively records developments related to new and emerging health
technologies. During the observation period from 2003 to 2007,
n = 15,552 datasets covering technological innovations in health
care could be identiﬁed from international publications and rel-
evant internet sources. In three broadly deﬁned application ﬁelds
(hormone therapy, cosmetics and interventions related to
improvement in cognition) upcoming health technologies were
identiﬁed from the database. Currently available technologies,
their intended use and potential future applications were
described. RESULTS: Regarding hormone therapy (n = 97 hits in
total) most frequently addressed indications were obesity
(n = 28), fertility (n = 15), contraception (n = 15), menopause
(n = 9), childhood growth (n = 8), and andropause (n = 6). Cos-
metic interventions (n = 47 in total) mostly addressed the treat-
ment of face (n = 20), skin (n = 13), and the female breast (n = 6).
Reports on cognition (n = 8) focused on the improvement of
the physical functioning (n = 5) or controlling of body parts/
prostheses (n = 3). For most technologies and applications,
however, it proved to be difﬁcult to distinguish a particular
“preference oriented” use from a potentially disease-related
assignment. CONCLUSIONS: Most innovations represent either
a minor improvement of an existing intervention or are still far
from possible routine use. Findings that speciﬁcally indicate
“preference based” applications were relatively rare. This leads
to the conclusion that research and development of new health
technologies primarily starts from a perceived demand for
serious diseases and clear-cut indications. Only subsequently
“preference oriented” uses may be addressed.
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OBJECTIVES: In the Dutch health care system, like many other
countries, the general practitioner (GP) plays a key role in secur-
ing equity and effectiveness in delivering health care. Nowadays,
GPs are often part of primary care centers and it is foreseen that
these centers will play an even more important role in future
health service delivery. A European comparison in nine different
countries concluded patients favour small practices and full time
GPs. The percentage of GPs working in small practices varies
between countries. In the UK the percentage is 16% whereas in
Belgium the percentage is 69% and in Netherlands the percent-
age is 39%. Continuity of care and access is highly appreciated
by patients. For instance, it has been shown that patients are
more satisﬁed with primary care if they always have the same GP
and if they experience short waiting times. Given the develop-
ment of larger primary care centers, people are hesitant if the
current GP service levels can be maintained. On the other hand,
an advantage of primary care centers is that they do offer mul-
tiple medical services like pharmacy and physiotherapy. The
purpose of this study was two-fold. First, it was questioned
which type of services is preferred by patients in three different
GP settings and if people would be willing to pay for these
services. Second, we wish to investigate differences between
patients in different GP settings. The selected GP settings were 1)
a single person GP practice (SP); 2) a healthservice with multiple
independent GPs (GP); and 3) a multi-disciplinary and compre-
hensive primary care center supervised by one management
(PCC). METHODS: A discrete choice experiment (DCE) was
carried out among 164 patients in the three different GP settings.
The DCE comprised 6 attributes including 1) time to appoint-
ment; 2) choice of time; 3) access by telephone; 4) consultation
time; 5) availability of other medical services and; 6) WTP.
Sample size for the DCE was estimated at about 45 patients in
each GP setting. The DCE included 6 attributes. The maximum
number of levels for an attribute was three, allowing 72 choice
combinations. The DCE survey used 15 random and 2 ﬁxed
choicesets. Following the DCE, all 164 and an extra group of 114
patients (278 in total) were interviewed by a research assistent.
Sampling was carried out to obtain equal group sizes (approx.
55) in each of the GP settings (SP, GP and PCC). DCE data were
analyzed using sawtooth software. This abstract reports the ﬁrst
preliminary analyses of the complete dataset. RESULTS: Socio-
economic (income and education) and demographic data (age
and gender) of patients in each of the GP settings were compa-
rable. The DCE showed preference for improved telephone ser-
vices and time to appointment as most important attributes.
Except for “time to appointment” no large differences were
found between the GP settings. Only patients in the GP group
accepted longer waiting times compared to SP and PCC. SP and
PCC patients did prefer to have access within 24 hours, whereas
GP patients accepted longer waiting times. Overall, most impor-
tant attributes were “time to appointment”, “access of service by
telephone” and “WTP”. The availability of pharmacy services
was preferred by all patients. About 50% of all patients werent
willing to pay for additional services. However, some 35% was
willing to pay an extra amount of €9 for each consult if they
would receive additional services. CONCLUSIONS: This study
shows a similar outcome compared to previous studies on access
to GP services. “Time to ﬁrst appointment” and “access by
telephone” are most important factors to consider by patients.
However, an interesting ﬁnding was that one third of all patients
were willing to pay for improved services. The DCE study didn’t
show big differences in preferences between patients in the dif-
ferent GP settings. In some aspects (e.g. accessability) the SP
scored better compared to PCC and GP.
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HEALTH LITERACY—AN ECONOMIC PERSPECTIVE:
A SYSTEMATIC REVIEW
Eichler K,Wieser S, Brügger U
Zurich University of Applied Sciences,Winterthur, Switzerland
OBJECTIVES: Health Literacy (HL) is an important skill for
health relevant decisions. Limited HL is associated with poorer
health outcomes but little is known about the economic impli-
cations of limited HL. We assessed 1) the costs of limited HL for
the health care system, and 2) the cost-effectiveness of interven-
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